The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index; 2 of the 3 sources its claims cite were checked for support.
Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients
Open accessAbstract
An integrated diagnostic approach using FNA cytology, ZN staining, auramine O, GeneXpert MTB/RIF and RT-PCR was evaluated against culture in suspected tuberculous lymphadenitis.
Overview
CoChat Summary
## TL;DR
This cross-sectional study of 96 clinically suspected tuberculous lymphadenitis (TBLN) patients found that FNAC and RT-PCR detected more cases than smear microscopy, and that combining FNAC with molecular tests improved diagnostic yield. The best-performing combined approach was FNAC plus GeneXpert MTB/RIF on concentrated FNA samples, which reached 100% sensitivity versus LJ culture.
## Key findings
- Among 96 FNA samples, detection rates were 12.5% by Ziehl-Neelsen (12/96), 28.1% by Auramine O (27/96), 53.2% by FNAC (51/96), 44.7% by GeneXpert MTB/RIF (43/96), 53.1% by RT-PCR (51/96), and 37.5% by LJ culture (36/96).
- Using LJ culture as the gold standard, sensitivities were 91.7% for GeneXpert MTB/RIF, 97.2% for RT-PCR, and 97.2% for FNAC; specificities were 83.3%, 73.3%, and 68.3%, respectively.
- Combining GeneXpert MTB/RIF and RT-PCR with FNAC detected 61 cases (63.5%) and yielded 100% sensitivity; specificity for the combined approach was 58.3%.
- Among culture-positive cases, the average LJ growth time was 3 to 6 weeks, and 4 samples were contaminated and excluded from analysis.
## Methods
- Cross-sectional study of 96 clinically diagnosed TBLN-suspected patients enrolled at ALERT Hospital in Addis Ababa between September 2020 and April 2021.
- Fine needle aspirate (FNA) samples were tested by FNAC, Ziehl-Neelsen staining, Auramine O staining, GeneXpert MTB/RIF, RT-PCR targeting IS1081, and LJ culture after concentration/decontamination of samples.
- Diagnostic performance was assessed against LJ culture using sensitivity, specificity, PPV, NPV, and Cohen’s kappa; analyses were done in SPSS 26.
## Limitations
- The paper states that culture was slow and that some FNA samples were mixed with blood, which “might have contributed” to lower GeneXpert positivity; this is an evident sample-quality limitation.
- Four samples were contaminated and excluded from analysis, which may have reduced the effective sample size; this is evident from the text.
- The study was conducted in one hospital with 96 patients, so generalizability is limited; this is evident from the study design and sample.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 0 Not valid · 0 Not checked · 62 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Same finding has been shown by Kant et al [14].”
§ Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients > Discussion
What the sources say
- Supportedcites [14] K Kant, 2019, Microbiological evaluation of clinically suspected cases of tubercular lymphadenopathy by cytology, culture, and smear microscopy–A hospital-based study from Northern India, Journal of Family Medicine and Primary Care source
The Results report that 24 of 54 samples suggestive of TB on FNAC were negative on Bactec culture, and give FNAC a specificity of 69% relative to that culture. The Discussion describes culture as more specific than FNAC. These passages support the attributed finding, though culture-negative results alone do not establish that every FNAC-positive case was a false positive. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Culture method also detected positive cases of 28.6% from all ZN negative cases.”
§ Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Out of the 96 FNA sample, 12 (12.5%) were identified to have Mycobacterium tuberculosis (Mtb) using ZN staining, 27 (28.1%) using AO staining, 51 (53.2%) using FNAC, 43 (44.7%) using GeneXpert MTB/RIF, 51 (53.1%) using Real time PCR (RT-PCR) and 36 (37.5%) using Lowenstein-Jensen (LJ) culture.”
§ Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients > Abstract > Result
plainn = 96- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“GeneXpert MTB/RIF assay relatively has better agreement with culture having a kappa value of 0.72”
- Also stated in: § Discussion · plain
“GeneXpert assay has a better agreement with culture having a kappa value of 0.72 and RT PCR with a kappa value of 0.65”
§ Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients > Discussion
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the sensitivity and specificity was 100% and 58.3%, respectively.”
§ Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients > Abstract > Result
plainn = 96- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
39 more claims
Create a free account to see all 64 claims and every source verdict.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 7
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“T-E Nur, 2019, Diagnosis of Tuberculous Lymphadenitis Using Fine Needle Aspiration Cytology: A Comparison Between Cytomorphology and GeneXpert Mycobacterium Tuberculosis Resistant to Rifampicin (MTB/RIF) Test, Clinical Infection and Immunity, 4, 6, 10.14740/cii77”
Cited work 10.14740/cii77 · retracted 2019-10-01 · notice 10.14740/cii77r · this paper published 2022-03-31
Citations
Cites
1 retracted
Nur, T.-E., Akther, S., Kamal, M., Shomik, M. S., Mondal, D., & Raza, A. K. M. M. (2019) · Clinical Infection and Immunity · doi:10.14740/cii77 · Cited by 4
RetractedMycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence
Smith, I. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.463-496.2003 · Cited by 1,154
Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017
Pang, Y., An, J., Shu, W., Huo, F., Chu, N., Gao, M., Qin, S., Huang, H., Chen, X., & Xu, S. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2503.180572 · Cited by 282
Diagnosis of extrapulmonary tuberculosis by PCR
Mehta, P. K., Raj, A., Singh, N., & Khuller, G. K. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00987.x · Cited by 194
Rapid Detection of Mycobacterium tuberculosis by Recombinase Polymerase Amplification
Boyle, D. S., McNerney, R., Teng Low, H., Leader, B. T., Pérez-Osorio, A. C., Meyer, J. C., O'Sullivan, D. M., Brooks, D. G., Piepenburg, O., & Forrest, M. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103091 · Cited by 164
van Soolingen, D., Hermans, P. W., de Haas, P. E., & van Embden, J. D. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.7.1772-1777.1992 · Cited by 139 · cited 1×
“RT PCR assay in this study targets IS1081 gene present in all MTBC and in a stable copy number of 5–7 repeats per genome [17, 18].”
MethodDiagnosis of tuberculous lymphadenitis by FNAC, microbiological methods and PCR: a comparative study
Aljafari, A. S., Khalil, E. A. G., Elsiddig, K. E., El Hag, I. A., Ibrahim, M. E., Elsafi, M. E. M. O., Hussein, A. M., Elkhidir, I. M., Sulaiman, G. S., & Elhassan, A. M. (2004) · Cytopathology · doi:10.1111/j.1365-2303.2003.00119.x · Cited by 103
Tadesse, M., Abebe, G., Abdissa, K., Aragaw, D., Abdella, K., Bekele, A., Bezabih, M., Apers, L., de Jong, B. C., & Rigouts, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137471 · Cited by 85 · cited 1×
“8% which was closer but still lower to what has been shown in this study [22].”
ResultBabafemi, E. O., Cherian, B. P., Banting, L., Mills, G. A., & Kandala, N.-B. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0608-2 · Cited by 56 · cited 1×
“This finding is not consistent with Babafemi et al, which showed a sensitivity of 70% and higher specificity of 99% [23].”
ResultYu, G., Zhong, F., Ye, B., Xu, X., Chen, D., & Shen, Y. (2019) · BioMed Research International · doi:10.1155/2019/4878240 · Cited by 52 · cited 1×
“Introduction Tuberculosis (TB) is generally caused by Mycobacterium tuberculosis (Mtb) complex and remains to be the major cause of death globally [1, 2].”
Background
Cited by
Chen, Z.-K., Wu, Z., Ye, T., Lin, C.-Y., & Guo, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321507 · Cited by 8
“In addition, the diagnostic accuracy of Xpert MTB/ RIF has been continuously reported in newly published articles [12–14], indicating its high clinical significance.”
Atnafu, A., Wassie, L., Tilahun, M., Girma, S., Zenebe, Y., Beyene, M. A., Alemu, A., Fisseha, E., Agze, H., Desta, T., et al. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s407866 · Cited by 8
“1Armauer Hansen Research Institute, Addis Ababa, Ethiopia; 2Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia; 3Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia *These authors…”
ResultInfluentialSelf-citationBaye, N., Atnafu, A., Girma, S., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09908-7 · Cited by 3
“Sample type usage might have also caused the discrepancy, Atnafu A et al have used fresh FNA samples [16].”
BackgroundSelf-citationSayed, M. H., & Sane, K. C. (2024) · Lung India · doi:10.4103/lungindia.lungindia_135_24 · Cited by 2
Performance of conventional laboratory tests and Xpert MTB/RIF in the diagnosis of tuberculosis
Zaporojan, N., Hodișan, R., Zaha, A. A., Zaporojan, C., & Zaha, D. C. (2025) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2025.3394 · Cited by 1
Metadata
- Authors
- Atnafu, A., Desta, K., Girma, S., Hailu, D., Assefa, G., Araya, S., Bekele, D., Wassie, L., & Bobosha, K.
- Affiliations
- Armauer Hansen Research Institute (ET)
- Addis Ababa University (ET)
- Corresponding author
- Atnafu, Abay
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-03-31
- Volume
- 17
- Issue
- 3
- Pages
- e0265499
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8970391
- OpenAlex
- W4220853009
- Cited by
- 6
- References
- 25
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 1
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Funders
- Styrelsen för Internationellt Utvecklingssamarbete
- Direktoratet for Utviklingssamarbeid
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphadenopathy Diagnosis and Analysis
- Keywords
- tuberculous lymphadenitis, Mycobacterium tuberculosis detection, fine needle aspiration cytology, Xpert MTB/RIF, RT-PCR, Ziehl-Neelsen staining, auramine O staining, Lowenstein-Jensen culture, sensitivity and specificity, integrated diagnostic approach, resource-limited settings, interobserver agreement, predictive value, unnecessary antibiotic use
- MeSH terms
- Cross-Sectional Studies, Humans, Mycobacterium tuberculosis, Sensitivity and Specificity, Tuberculosis, Lymph Node, Biopsy, Fine-Needle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients. https://app.cochat.ai/papers/10.1371/journal.pone.0265499
- The paper
- Atnafu, A., Desta, K., Girma, S., Hailu, D., Assefa, G., Araya, S., Bekele, D., Wassie, L., & Bobosha, K. (2022). Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients. PLoS ONE. https://doi.org/10.1371/journal.pone.0265499
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.